Overview
Cerebral pseudoatrophy refers to a condition characterized by apparent brain atrophy on imaging that is not reflective of true neuronal loss but rather transient changes in cerebral vasculature, often reversible. This phenomenon can be associated with various etiologies including infectious agents, medication side effects, and vascular spasm 12.Diagnosis
Clinical Presentation: Often includes focal neurological deficits that may be transient.
Imaging Findings: MRI showing areas of apparent atrophy or ischemic changes that may normalize over time.
Angiographic Studies: MRA or HRMRI to identify segmental stenosis or vascular abnormalities 12.
Lumbar Puncture: Useful for detecting infectious agents like enterovirus 1.
Differential Diagnosis: Exclude true neurodegenerative processes by clinical context and imaging evolution 1.Management
Supportive Care: Focus on managing symptoms and preventing complications.
Etiologic Treatment: Address underlying causes such as discontinuing ergot derivatives if applicable 2.
Monitoring: Regular MRI and MRA follow-ups to assess reversibility of changes 12.
Infection Management: Antiviral or antibiotic therapy if an infectious etiology is identified 1.Special Populations
Pediatrics: Transient cerebral arteriopathy can occur, often linked to infectious causes like enterovirus 1.
Medication Sensitivity: Ergot derivatives pose a risk in various populations, especially with excessive dosing 2.Key Recommendations
Initiate imaging follow-up with MRI and MRA to monitor reversibility of cerebral pseudoatrophy changes (Evidence: Moderate 12).
Identify and treat underlying causes such as discontinuing ergot derivatives or managing infections (Evidence: Moderate 21).
Consider lumbar puncture in pediatric cases or when infectious etiology is suspected (Evidence: Weak 1).References
1 Piccolo B, Barsacchi M, Greco F, Cerasti D, Ormitti F, Pisani F. Transient posterior cerebral arteriopathy: An unusual case enterovirus-related. Brain & development 2019. link
2 Henry PY, Larre P, Aupy M, Lafforgue JL, Orgogozo JM. Reversible cerebral arteriopathy associated with the administration of ergot derivatives. Cephalalgia : an international journal of headache 1984. link
3 Cervós-Navarro J, Matakas F, Roggendorf W, Christmann U. The morphology of spastic intracerebral arterioles. Neuropathology and applied neurobiology 1978. link